U.S. flag

An official website of the United States government

NM_000238.4(KCNH2):c.2350C>T (p.Arg784Trp) AND Long QT syndrome

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Aug 15, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001851875.12

Allele description [Variation Report for NM_000238.4(KCNH2):c.2350C>T (p.Arg784Trp)]

NM_000238.4(KCNH2):c.2350C>T (p.Arg784Trp)

Gene:
KCNH2:potassium voltage-gated channel subfamily H member 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q36.1
Genomic location:
Preferred name:
NM_000238.4(KCNH2):c.2350C>T (p.Arg784Trp)
HGVS:
  • NC_000007.14:g.150950216G>A
  • NG_008916.1:g.32711C>T
  • NM_000238.4:c.2350C>TMANE SELECT
  • NM_001204798.2:c.1330C>T
  • NM_001406753.1:c.2062C>T
  • NM_001406755.1:c.2173C>T
  • NM_001406756.1:c.2062C>T
  • NM_001406757.1:c.2050C>T
  • NM_172056.3:c.2350C>T
  • NM_172057.3:c.1330C>T
  • NP_000229.1:p.Arg784Trp
  • NP_000229.1:p.Arg784Trp
  • NP_001191727.1:p.Arg444Trp
  • NP_001393682.1:p.Arg688Trp
  • NP_001393684.1:p.Arg725Trp
  • NP_001393685.1:p.Arg688Trp
  • NP_001393686.1:p.Arg684Trp
  • NP_742053.1:p.Arg784Trp
  • NP_742053.1:p.Arg784Trp
  • NP_742054.1:p.Arg444Trp
  • NP_742054.1:p.Arg444Trp
  • LRG_288t1:c.2350C>T
  • LRG_288t2:c.2350C>T
  • LRG_288t3:c.1330C>T
  • LRG_288:g.32711C>T
  • LRG_288p1:p.Arg784Trp
  • LRG_288p2:p.Arg784Trp
  • LRG_288p3:p.Arg444Trp
  • NC_000007.13:g.150647304G>A
  • NM_000238.3:c.2350C>T
  • NM_172056.2:c.2350C>T
  • NM_172057.2:c.1330C>T
  • NR_176254.1:n.2758C>T
  • NR_176255.1:n.1631C>T
  • Q12809:p.Arg784Trp
Protein change:
R444W; ARG784TRP
Links:
UniProtKB: Q12809#VAR_036676; OMIM: 152427.0014; dbSNP: rs12720441
NCBI 1000 Genomes Browser:
rs12720441
Molecular consequence:
  • NM_000238.4:c.2350C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001204798.2:c.1330C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406753.1:c.2062C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406755.1:c.2173C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406756.1:c.2062C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406757.1:c.2050C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_172056.3:c.2350C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_172057.3:c.1330C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
4

Condition(s)

Name:
Long QT syndrome (LQTS)
Identifiers:
MONDO: MONDO:0002442; MeSH: D008133; MedGen: C0023976

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002205738Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Sep 13, 2022)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

SCV004843913All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain Significance
(Aug 15, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown4not providednot provided108544not providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.

Yang P, Kanki H, Drolet B, Yang T, Wei J, Viswanathan PC, Hohnloser SH, Shimizu W, Schwartz PJ, Stanton M, Murray KT, Norris K, George AL Jr, Roden DM.

Circulation. 2002 Apr 23;105(16):1943-8.

PubMed [citation]
PMID:
11997281
See all PubMed Citations (9)

Details of each submission

From Invitae, SCV002205738.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 784 of the KCNH2 protein (p.Arg784Trp). This variant is present in population databases (rs12720441, gnomAD 0.002%). This missense change has been observed in individuals with clinical features of long QT syndrome (PMID: 11997281, 15840476, 19841300, 22949429). ClinVar contains an entry for this variant (Variation ID: 14433). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects KCNH2 function (PMID: 11997281, 25417810). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From All of Us Research Program, National Institutes of Health, SCV004843913.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided4not providednot providedclinical testing PubMed (8)

Description

This missense variant replaces arginine with tryptophan at codon 784 of the KCNH2 protein. Computational prediction suggests that this variant may have a deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). In vitro experimental functional studies have shown that this variant may result in deficient protein trafficking (PMID: 25417810), reduced channel current (PMID: 11997281) and faster channel deactivation compared to wild type (PMID: 19172259). This variant has been reported in two individuals affected with long QT syndrome (PMID: 19841300, 22949429) and in an individual suspected to be affected with long QT syndrome (PMID: 15840476). This variant has also been reported in two individuals affected with drug-induced torsades de pointes, a form of ventricular tachycardia (PMID: 11997281, 24223155). This variant has been identified in 3/282186 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided4not providednot providednot provided

Last Updated: Sep 16, 2024